These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18055575)

  • 1. Non-destructive mechanical characterisation of UVA/riboflavin crosslinked collagen hydrogels.
    Ahearne M; Yang Y; Then KY; Liu KK
    Br J Ophthalmol; 2008 Feb; 92(2):268-71. PubMed ID: 18055575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermomechanical behavior of collagen-cross-linked porcine cornea.
    Spoerl E; Wollensak G; Dittert DD; Seiler T
    Ophthalmologica; 2004; 218(2):136-40. PubMed ID: 15004504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen cross-linking treatment effects on corneal dynamic biomechanical properties.
    Hatami-Marbini H; Rahimi A
    Exp Eye Res; 2015 Jun; 135():88-92. PubMed ID: 25887295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure.
    Krueger RR; Herekar S; Spoerl E
    Eye Contact Lens; 2014 Nov; 40(6):353-7. PubMed ID: 25365552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking.
    Wollensak G; Spoerl E; Seiler T
    J Cataract Refract Surg; 2003 Sep; 29(9):1780-5. PubMed ID: 14522301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of UVA-riboflavin crosslinking to enhance the mechanical properties of extracellular matrix derived hydrogels.
    Ahearne M; Coyle A
    J Mech Behav Biomed Mater; 2016 Feb; 54():259-67. PubMed ID: 26476968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment.
    Wollensak G; Spoerl E; Wilsch M; Seiler T
    Cornea; 2004 Jan; 23(1):43-9. PubMed ID: 14701957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of UVA/Riboflavin Collagen Crosslinking on Biomechanics of Artificially Swollen Corneas.
    Hatami-Marbini H; Jayaram SM
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):764-770. PubMed ID: 29392322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural response of human corneal and scleral tissues to collagen cross-linking treatment with riboflavin and ultraviolet A light.
    Choi S; Lee SC; Lee HJ; Cheong Y; Jung GB; Jin KH; Park HK
    Lasers Med Sci; 2013 Sep; 28(5):1289-96. PubMed ID: 23179311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evaluation of Corneal Fragility After UVA/Riboflavin Crosslinking.
    Li Z; Wang Y; Xu Y; Jhanji V; Zhang C; Mu G
    Eye Contact Lens; 2017 Mar; 43(2):100-102. PubMed ID: 28079590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stiffening effects of riboflavin/UVA corneal collagen cross-linking is hydration dependent.
    Hatami-Marbini H; Rahimi A
    J Biomech; 2015 Apr; 48(6):1052-7. PubMed ID: 25704532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus.
    Wollensak G; Spoerl E; Seiler T
    Am J Ophthalmol; 2003 May; 135(5):620-7. PubMed ID: 12719068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea.
    Zhu Y; Reinach PS; Zhu H; Tan Q; Zheng Q; Qu J; Chen W
    PLoS One; 2017; 12(6):e0179580. PubMed ID: 28644862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA.
    Wollensak G; Wilsch M; Spoerl E; Seiler T
    Cornea; 2004 Jul; 23(5):503-7. PubMed ID: 15220736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas].
    Schilde T; Kohlhaas M; Spoerl E; Pillunat LE
    Ophthalmologe; 2008 Feb; 105(2):165-9. PubMed ID: 17955247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of UVA-riboflavin cross-linking of the cornea.
    Spoerl E; Mrochen M; Sliney D; Trokel S; Seiler T
    Cornea; 2007 May; 26(4):385-9. PubMed ID: 17457183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased resistance of crosslinked cornea against enzymatic digestion.
    Spoerl E; Wollensak G; Seiler T
    Curr Eye Res; 2004 Jul; 29(1):35-40. PubMed ID: 15370365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.
    Wollensak G; Spoerl E; Reber F; Seiler T
    Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riboflavin as a dentin crosslinking agent: ultraviolet A versus blue light.
    Fawzy AS; Nitisusanta LI; Iqbal K; Daood U; Neo J
    Dent Mater; 2012 Dec; 28(12):1284-91. PubMed ID: 23031483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal crosslinking with riboflavin and UVA for the treatment of keratoconus.
    Kymionis G; Portaliou D
    J Cataract Refract Surg; 2007 Jul; 33(7):1143-4; author reply 1144. PubMed ID: 17586362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.